CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

valeant offers to acquire cephalon for $5.7b

  1. 27 Posts.
    Valeant Pharmaceuticals International Inc. , a Canadian pharma focused on neurology and dermatology, made a hostile bid to buy Cephalon Inc. for about $5.7 billion, or $73 a share in cash.

    How will this impact the CXS deal??
 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.